000 01805 a2200493 4500
005 20250518073401.0
264 0 _c20191213
008 201912s 0 0 eng d
022 _a1791-7530
024 7 _a10.21873/anticanres.13878
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHan, Hye Rim
245 0 0 _aEvaluation of Combination Treatment Effect With TRAIL-secreting Mesenchymal Stem Cells and Compound C Against Glioblastoma.
_h[electronic resource]
260 _bAnticancer research
_cDec 2019
300 _a6635-6643 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAMP-Activated Protein Kinases
_xantagonists & inhibitors
650 0 4 _aAnimals
650 0 4 _aApoptosis
650 0 4 _aBrain Neoplasms
_xmetabolism
650 0 4 _aCASP8 and FADD-Like Apoptosis Regulating Protein
_xmetabolism
650 0 4 _aCaspase 3
_xmetabolism
650 0 4 _aCombined Modality Therapy
650 0 4 _aGlioblastoma
_xmetabolism
650 0 4 _aHeterografts
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMesenchymal Stem Cell Transplantation
650 0 4 _aMesenchymal Stem Cells
_xmetabolism
650 0 4 _aMice
650 0 4 _aMice, Nude
650 0 4 _aProto-Oncogene Proteins c-bcl-2
_xmetabolism
650 0 4 _aPyrazoles
_xtherapeutic use
650 0 4 _aPyrimidines
_xtherapeutic use
650 0 4 _aTNF-Related Apoptosis-Inducing Ligand
_xmetabolism
650 0 4 _aX-Linked Inhibitor of Apoptosis Protein
_xmetabolism
650 0 4 _abcl-2-Associated X Protein
_xmetabolism
700 1 _aPark, Soon A
700 1 _aAhn, Stephen
700 1 _aJeun, Sin-Soo
700 1 _aRyu, Chung Heon
773 0 _tAnticancer research
_gvol. 39
_gno. 12
_gp. 6635-6643
856 4 0 _uhttps://doi.org/10.21873/anticanres.13878
_zAvailable from publisher's website
999 _c30394911
_d30394911